logo
Select company
Select metric
$ -10.27MConsolidated Income
VS
Market
35
Sector
67
Industry
81
History
3
$ 7.63Close
$ 3.85 - $ 10.72 52-Week Range
Ticker Information

Ticker

NTRB

Company Name

NUTRIBAND INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NUTRIBAND INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NTRB - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -10.27M
3/31/2025$ -9.97M
12/31/2024$ -10.48M
9/30/2024$ -6.85M
6/30/2024$ -7.24M
3/31/2024$ -6.37M
12/31/2023$ -5.49M
9/30/2023$ -5.28M
6/30/2023$ -4.6M
3/31/2023$ -4.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUTRIBAND INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -1.63M.
  • Over the past 5 years, NUTRIBAND INC's average Cons. Inc. has been $ -5.87M.
  • The median Cons. Inc. for NUTRIBAND INC during this period was $ -5.83M
  • NUTRIBAND INC reached its highest Cons. Inc. over the past 5 years at $ -1.63M.
  • The lowest Cons. Inc. recorded by NUTRIBAND INC in the same timeframe $ -10.48M

NUTRIBAND INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
PYXS : PYXIS ONCOLOGY INC $ -96.29MORMP : ORAMED PHARMACEUTICALS INC $ -24.22MALGS : ALIGOS THERAPEUTICS INC $ -74.18MSTTK : SHATTUCK LABS INC $ -61.51MCAMP : CAMP4 THERAPEUTICS CORP $ -51.78MDTIL : PRECISION BIOSCIENCES INC $ -78.25MARMP : ARMATA PHARMACEUTICALS INC $ -25.71MOTLK : OUTLOOK THERAPEUTICS INC $ -43.44MABVC : ABVC BIOPHARMA INC $ -3.28MVTGN : VISTAGEN THERAPEUTICS INC $ -55.78M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

NTRB - Consolidated Income, Last 5 years

$ -10.48M

Minimum

Dec 31, 2024

$ -1.63M

Maximum

Sep 30, 2020

$ -5.87M

Average

$ -5.83M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M